Literature DB >> 8551418

Bone density in children and adolescents with cystic fibrosis.

R C Henderson1, C D Madsen.   

Abstract

OBJECTIVE: To assess bone mineralization in children and adolescents with cystic fibrosis.
DESIGN: A cross-sectional, observational study of bone mineral density (BMD) in the lumbar vertebrae and the proximal femur of 62 patients aged 4.9 to 17.8 years (mean, 10.7 years). The age-normalized BMD findings (z scores) were correlated with multiple variables, including measures of pulmonary disease, nutritional status and growth, genotype, calcium intake, and serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels.
RESULTS: The mean BMD z score was -1.03 +/- 0.14 (+/- SE) in the lumbar vertebrae and -0.71 +/- 0.17 in the proximal femur. The BMD in this age range declined relative to normal values at a rapid rate of roughly 1 SD every 6 to 8 years. The BMD z scores correlated well with multiple measures of disease severity, particularly weight and forced expiratory volume in 1 second.
CONCLUSIONS: Significant osteoporosis in adults with CF results at least in part from a failure to accumulate bone mineral at a normal rate during skeletal growth and development. The cause of this is likely multifactorial. With increasing longevity, the skeletal consequences of CF become an important consideration.

Entities:  

Mesh:

Year:  1996        PMID: 8551418     DOI: 10.1016/s0022-3476(96)70424-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  24 in total

Review 1.  Assessment of bone mass following renal transplantation in children.

Authors:  Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

2.  The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis.

Authors:  Polyxeni Nicolaidou; Ilias Stavrinadis; Ioanna Loukou; Anna Papadopoulou; Helen Georgouli; Konstantinos Douros; Kostas N Priftis; Dimitrios Gourgiotis; Yiannis G Matsinos; Stavros Doudounakis
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

3.  Bone mineral status in 134 patients with cystic fibrosis.

Authors:  E M Laursen; C Molgaard; K F Michaelsen; C Koch; J Müller
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

4.  Factors associated with low bone mineral density in patients with cystic fibrosis.

Authors:  Shahid Sheikh; Susan Gemma; Alpa Patel
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

5.  Calcium acquisition rates do not support age-appropriate gains in total body bone mineral content in prepuberty and late puberty in girls with cystic fibrosis.

Authors:  K J Schulze; C Cutchins; B J Rosenstein; E L Germain-Lee; K O O'Brien
Journal:  Osteoporos Int       Date:  2006-02-28       Impact factor: 4.507

6.  Bone mineral and body composition alterations in paediatric cystic fibrosis patients.

Authors:  Philippe Reix; Gabriel Bellon; Pierre Braillon
Journal:  Pediatr Radiol       Date:  2009-12-03

7.  Vitamin d deficiency in cystic fibrosis.

Authors:  William B Hall; Amy A Sparks; Robert M Aris
Journal:  Int J Endocrinol       Date:  2010-01-28       Impact factor: 3.257

8.  Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Authors:  S A Brown; D A Ontjes; G E Lester; R K Lark; M B Hensler; A D Blackwood; M J Caminiti; D C Backlund; R M Aris
Journal:  Osteoporos Int       Date:  2003-05-28       Impact factor: 4.507

9.  Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study.

Authors:  H M Buntain; R M Greer; P J Schluter; J C H Wong; J A Batch; J M Potter; P J Lewindon; E Powell; C E Wainwright; S C Bell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

10.  Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Authors:  C M Gordon; E Binello; M S LeBoff; M E Wohl; C J Rosen; A A Colin
Journal:  Osteoporos Int       Date:  2006-03-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.